NEW NANOTHERAPY RESEARCH FOR INFLAMMATORY BOWEL DISEASES
THE NEW DEAL CONCEPT COULD REVOLUTIONIZE IBD THERAPIES FOR THE GREAT BENEFIT OF PATIENTS AND EUROPEAN HEALTHCARE SYSTEMS.
- Dr. Fabrice NAVARRO, New Deal Project Coordinator
THE PROJECT GOALS
THE PROJECT GOALS
The NEW DEAL project aims to develop a highly selective and local therapy with an improved efficacy and safety profile for IBD patients. This treatment might be an alternative to the existing therapies.
Design and validate a radically improved IBD therapy that specifically targets JAK1 / JAK3 inhibition by means of siRNA and RNAi interference.
Develop advanced technologies for delivering siJAK1 / siJAK3 locally to the inflamed gut
Promote the clinical translation and the future industrial transfer of this new clinical product for IBD therapy.
THE PROJECT NEWS
May New Deal Reads
The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn’s & Colitis Foundation. Park, K. T. et [...]
Let’s talk about it: The gut-brain dialogue, third edition of our IBD&Tea event
In our busy and fast world, mental health is becoming more and more important. Our emotional, psychological and [...]
February New Deal Reads
Oral nanoparticles of SNX10-shRNA plasmids ameliorate Mouse Colitis. W.Bao, Q.Wu, B.Hu, D.Sun, S.Zhao, X.Shen, H.Cheng & W.Shen. Int [...]
January New Deal Reads
Inflammatory Bowel Disease: The Emergence of New Trends in Lifestyle and Nanomedicine as the Modern Tool for Pharmacotherapy. [...]
THE PROJECT PARTNERS
THE PROJECT PARTNERS
